Yahoo Canada Web Search

Search results

  1. Mario Natalino Concetto Amendola (8 December 1910 – 22 December 1993) was an Italian screenwriter, film director and dramatist. Biography. Amendola was born in Recco, which is located in Genova to parents from Rome. He began his career on stage in 1931 as a writer for avanspettacolo shows.

  2. Mario Amendola was born on 8 December 1910 in Recco, Liguria, Italy. He was a writer and director, known for Trappola per sette spie (1966), Sword of Damascus (1964) and Who Finds a Friend Finds a Treasure (1981). He died on 22 December 1993 in Rome, Lazio, Italy.

  3. 2019-today: Review Editor inGenome Editing in Blood Disorders” (Frontiers in Genome Editing) rapies (Frontiers in Medicine)Journal reviewer for: Trends in Biotechnology, BMC genomics, Nucleic Acids Research, Molecular Therapy, Gene Thera.

  4. French National Centre for Scientific Research. Mario AMENDOLA, Group Leader | Cited by 650 | of Généthon, Évry | Read 4 publications | Contact Mario AMENDOLA.

  5. Associate Professor of Molecular Biology, University of Foggia, Italy . e de 1ère classe (CR1) INSERM, UMR_S951, Evry, FR. Team Leader of the ‘Ther. Amsterdam, NL (Supervisor Prof. Bas van Steensel). Topic: ‘Role of Lamins and Nuclear Envelope Pro.

  6. www.genethon.com › our-science › our-research-teamsGene Editing - Généthon

    Gene Editing team. The team is mainly focused on the development of efficient and safe gene editing techniques to treat rare genetic diseases in vivo and ex vivo. The team’s researchers. Mario Amendola, PhD. Guillaume Corre, PhD. The team’s projects. Current projects are focused on several themes:

  7. Mario AMENDOLA, PostDoc Position | Cited by 6,350 | of Netherlands Cancer Institute, Amsterdam | Read 53 publications | Contact Mario AMENDOLA

  8. Recent advances in genome editing tools, especially novel developments in the clustered regularly interspaced short palindromic repeats associated to Cas9 nucleases (CRISPR/Cas9)-derived editing machinery, have revolutionized not only basic science but, importantly, also the gene therapy field.

  9. Jul 18, 2019 · Mario AMENDOLA. CR 1 INSERM, Group Leader “Therapeutic genome editing” Genethon, Evry, FRANCE. Monday 1 July 2019 | 12:00 noon. Ex vivo editing of HSC for erythroid- specific expression of therapeutic proteins. Host: A. Muro.

  10. Read articles by Mario Amendola on ScienceDirect, the world's leading source for scientific, technical, and medical research.

  1. Related searches

    mario amendola net worth